Predictive biomarkers for cancer immunotherapy and methods of using same
US11643691B2 · kind B2 · utility
0Cited by
5References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 2019 |
| Grant date | May 9, 2023 |
| Priority date | — |
| Expiry date | Mar 9, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides methods of detecting a wnt-β-catenin-mediated cancer and an immunotherapy resistant cancer by detecting the presence of an associated biomarker. Further, methods of threating the wnt-β-catenin-mediated cancer or immunotherapy resistant cancer are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.